Dongliang Lin Casi Pharmaceuticals, Inc

As of November 14, 2018


Dongliang Lin Net Worth

  • Net worth is estimated to be at least $14.79M
  • Owns at least 8,498,765 units of Casi Pharmaceuticals, Inc stock

Dongliang Lin Trading

  • Largest purchase of shares was 3,753,855 units , worth over $4.47M on June 29, 2016
  • In total has made about 2 transactions over 2 years
  • Usually trades in November and June, with the busiest year in 2016 and 2018

SPARKLE BYTE LTD, SNOW MOON LTD, PARTNERSHIP LIMITED CENTER MANAGEMENT JINGRAN TIANJIN, HE XIE AI QI INVESTMENT MANAGEMENT BEIJING CO LTD, Jianguang Li, Dongliang Lin, Fei Yang, Hugo Shong

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Dongliang Lin Mailing Address

  • Mailing address is 6/f, Tower A, Cofco Plaza 8 Jianguomennei Avenue Beijing F4 100005 China

Casi Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Wei-Wu He, Ph.D. 2020 $577,656 - - - - $241,831 $819,487
Wei-Wu He, Ph.D. 2019 $423,848 - - $8,600,000 - $241,555 $9,265,103
Wei (Larry) Zhang 2020 $437,094 - - - - $278,675 $715,769
Wei (Larry) Zhang 2019 $339,207 - - $450,000 - $166,889 $985,186
Alexander Zukiwski, MD 2020 $414,529 - - - - $28,250 $442,779
Alexander Zukiwski, MD 2019 $407,600 $100,000 - $426,000 - $27,750 $961,350
Weihao Xu 2020 $14,583 - - $1,440,000 - - $1,454,583
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/895051/000110465921063604/tm2114348d2_def14a.htm

Casi Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 480,000 units bought on August 20, 2021 by Wei-Wu He worth over $613.8K
  • In the last 5 years, insiders at Casi Pharmaceuticals, Inc sold an estimated value of $5.53M and bought an estimated value of $54.37M
  • The most active traders are Wei-Wu He, Chairman and CEO,  Cynthia W Hu, COO,  and Ken K. Ren, Director
  • Insider trading is most common in June, with the busiest year in 2016

CASI Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1